When semaglutide GLP-1 is introduced, it binds to the same receptors as GLP-1, leading to increased feelings of satiety, or fullness
Risk factors that may prompt additional consideration include: Active gastrointestinal symptoms (nausea, vomiting, abdominal pain) Recent dose increases or being in the dose-escalation phase Higher doses of semaglutide Known gastroparesis or other conditions affecting gastric emptying Obesity with GERD or hiatal hernia Based on the 2024 multi-society guidance, most patients can continue GLP-1 receptor agonists before elective procedures with appropriate risk assessment and mitigation strategies, rather than automatic postponement
While it is unclear how widespread the practice is, internet forums including Reddit have numerous examples of people reporting that they have been injecting themselves with such DIY preparations
No, diarrhea from semaglutide is typically temporary and improves as the body adjusts to the medication, usually within a few days to several weeks
Phentermine's controlled-substance status and stimulant profile, and semaglutide's thyroid C-cell boxed warning and GI profile, screen out different patients